Manufacturing
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
October 22, 2024
Driven by Science: Alnylam Named a Science Magazine Top Employer 6 Years in a Row
Alnylam has been named a top science employer by Science magazine for the 6th year in a row.
Read More ›
September 12, 2024
RNAi Therapeutics, from Possibility to Patients
The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine.
Read More ›
December 4, 2023
Being a Steward of the Planet in an Energy-Intensive Industry
Learn about how Alnylam is sourcing renewable energy for energy-intensive operations including manufacturing
Read More ›
February 4, 2022
Alnylam Receives Prestigious Massachusetts Economic Impact Award
We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon.
Read More ›
October 1, 2019
The Importance of Ensuring Quality in a New Class of Medicines
In Product Quality, we have a truly big picture view of the medicines we’re making to ensure they are compliant with good manufacturing practices and...
Read More ›
October 1, 2019
Building for Our Future
Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract...
Read More ›
